Abstract
CT perfusion (CTP) is a functional imaging technique that provides important information about capillary-level hemodynamics of the brain parenchyma and is a natural complement to the strengths of unenhanced CT and CT angiography in the evaluation of acute stroke, vasospasm, and other neurovascular disorders. CTP is critical in determining the extent of irreversibly infarcted brain tissue (infarct "core") and the severely ischemic but potentially salvageable tissue ("penumbra"). This is achieved by generating parametric maps of cerebral blood flow, cerebral blood volume, and mean transit time.
Highlights
Part 1 of this review established the clinical context of CT perfusion (CTP).[1]
A discussion followed on CTP map construction using the maximum slope method and the 2 main deconvolution techniques, Fourier transformation and singular value decomposition (SVD)
The review highlights the need for validation and standardization of important CTP parameters to improve patient outcomes and design future randomized clinical trials that will provide evidence for the importance of the core/ penumbra “mismatch” in patient triage for recanalization therapies beyond the current 3-hour therapeutic window for intravenous thrombolysis
Summary
Theoretic Basis and Technical Implementations of CT Perfusion in Acute Ischemic Stroke, Part 2: Technical Implementations. SUMMARY: CT perfusion (CTP) is a functional imaging technique that provides important information about capillary-level hemodynamics of the brain parenchyma and is a natural complement to the strengths of unenhanced CT and CT angiography in the evaluation of acute stroke, vasospasm, and other neurovascular disorders. CTP is critical in determining the extent of irreversibly infarcted brain tissue (infarct “core”) and the severely ischemic but potentially salvageable tissue (“penumbra”). This is achieved by generating parametric maps of cerebral blood flow, cerebral blood volume, and mean transit time. The review highlights the need for validation and standardization of important CTP parameters to improve patient outcomes and design future randomized clinical trials that will provide evidence for the importance of the core/ penumbra “mismatch” in patient triage for recanalization therapies beyond the current 3-hour therapeutic window for intravenous thrombolysis
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
